Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia; Recurrent Acute Myeloid Leukemia

Interventions: Other: Best Practice; Procedure: Biospecimen Collection; Drug: Cytarabine; Other: Electronic Health Record Review; Drug: Placebo Administration; Other: Xylitol-containing Oral Wipe

Sponsors: Children’s Oncology Group

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 3, 2026Comments OffClinicalTrials.gov | Dental Studies | Oncology Clinical Trials | US National Library of Medicine
Comments